Perrigo Migraine Analgesic, Antifungal Slated for Spring Launch
This article was originally published in The Tan Sheet
Executive Summary
Perrigo has become the first firm to receive FDA approval for both a generic migraine analgesic and a one-day vaginal antifungal treatment, the company announced Dec. 4